Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis.

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol (2014) 3.61

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46

Door-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc (2014) 0.95

M2 occlusions as targets for endovascular therapy: comprehensive analysis of diffusion/perfusion MRI, angiography, and clinical outcomes. J Neurointerv Surg (2014) 0.94

Time to endovascular reperfusion and degree of disability in acute stroke. Ann Neurol (2015) 0.92

Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes. Stroke (2014) 0.91

Clinical experience with the pREset stent retriever for the treatment of acute ischemic stroke--a review of 271 consecutive cases. Neuroradiology (2014) 0.90

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke (2015) 0.88

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke (2015) 0.88

Stent-Retriever Thrombectomy for Acute Anterior Ischemic Stroke with Tandem Occlusion: A Systematic Review and Meta-Analysis. Eur Radiol (2016) 0.86

Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology. J Vasc Interv Neurol (2014) 0.84

Cytoprotective-selective activated protein C therapy for ischaemic stroke. Thromb Haemost (2014) 0.84

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke (2014) 0.83

Predictors of a Good Outcome after Endovascular Stroke Treatment with Stent Retrievers. ScientificWorldJournal (2015) 0.82

Acute ischemic stroke treatment, part 1: patient selection "the 50% barrier and the capillary index score". Front Neurol (2015) 0.79

Mechanical thrombectomy using a combined CT/C-arm X-ray system. J Neurointerv Surg (2015) 0.78

Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices. Stroke (2013) 0.78

Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project. J Am Heart Assoc (2014) 0.77

Mechanical thrombectomy in patients with acute basilar occlusion using stent retrievers. Interv Neuroradiol (2015) 0.75

Clinical and radiological outcome after mechanical thrombectomy in acute ischemic stroke: What matters? Neuroradiol J (2016) 0.75

The 'pit-crew' model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project. J Neurointerv Surg (2016) 0.75

Brain hemorrhage after endovascular reperfusion therapy of ischemic stroke: a threshold-finding whole-brain perfusion CT study. J Cereb Blood Flow Metab (2015) 0.75

Modern interventional management of stroke. Methodist Debakey Cardiovasc J (2014) 0.75

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 14.49

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke (2007) 12.77

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58

Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75

Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke (2007) 5.55

Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation (2007) 5.28

Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83

Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31

Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol (2009) 3.88

Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology (2012) 3.62

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56

Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke (2010) 3.56

Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36

Very early administration of progesterone for acute traumatic brain injury. N Engl J Med (2014) 3.20

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00

Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94

Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke (2007) 2.93

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke (2011) 2.80

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74

Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke (2007) 2.74

Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology (2013) 2.60

The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56

Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55

Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.55

US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke (2009) 2.54

Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50

New England Medical Center Posterior Circulation registry. Ann Neurol (2004) 2.42

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41

Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36

Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol (2005) 2.36

Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36

ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg (2014) 2.34

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 2.33

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation (2003) 2.30

Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke (2006) 2.27

Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26

Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke (2005) 2.24

Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology (2003) 2.22

Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke (2006) 2.22

Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke (2006) 2.20

Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Stroke (2003) 2.20

Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest (2003) 2.20

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16

Factors and outcomes associated with early and delayed aneurysm treatment in subarachnoid hemorrhage patients in the United States. Neurosurgery (2012) 2.15

Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke (2010) 2.12

Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke (2009) 2.10

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06

The use of vascular closure devices outside the catheterization laboratory after neurointerventional procedures is safe and effective: evidence from a retrospective study. J Endovasc Ther (2012) 2.03

Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke (2007) 2.03

Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. J Neurosurg (2014) 2.01

The emergence of endovascular treatment-only centers for treatment of intracranial aneurysms in the United States. J Stroke Cerebrovasc Dis (2013) 2.00

Non-ST-elevation myocardial infarction in patients undergoing carotid endarterectomy or carotid artery stent placement. Stroke (2013) 1.98

Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion. Stroke (2007) 1.97

Outcomes of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients in the United States. J Stroke Cerebrovasc Dis (2013) 1.91

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke (2012) 1.91

Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ Res (2003) 1.89

Use of the microangiographic fluoroscope for coiling of intracranial aneurysms. Neurosurgery (2011) 1.89

Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke (2010) 1.88

Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 1.85

Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol (2010) 1.85

Morphology parameters for intracranial aneurysm rupture risk assessment. Neurosurgery (2008) 1.83

Treatment of intracranial aneurysms with the Enterprise stent: a multicenter registry. J Neurosurg (2009) 1.83

Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81

Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke (2004) 1.81

Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke (2002) 1.80

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79

C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke (2003) 1.78

Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke (2004) 1.78

Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke (2012) 1.76

Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75